Skip to content

Understanding Cancer in the Elderly: Geriatric and oncology assessment

Understanding Cancer in the Elderly: A combined Retrospective and Prospective Analysis from the Geriatric Oncology Clinic at AIIMS, New Delhi - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/05/087507
Enrollment
2000
Registered
2025-05-23
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-D49- Neoplasms

Interventions

Control Intervention1: Nil: NIl

Sponsors

Reseach section AIIMS
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. All treatment naïve patients with diagnosis of malignancy 2. ECOG performance status 0 to 3

Exclusion criteria

Exclusion criteria: 1. Patients requiring radiotherapy intervention 2. Patients/ caregivers refuse for geriatric assessment 3. Patients refuse to give written informed consent 4. Patients having major neurological or medical disorder that impairs their ability to understand the study and give written informed consent

Design outcomes

Primary

MeasureTime frame
geriatric vulnerabilitiesTimepoint: at 3 months, 6 months and 1 year

Secondary

MeasureTime frame
quality of life of patientsTimepoint: at baseline, 3 months and 6 months;Chemotherapy toxicity risk assessmentTimepoint: 3 and 6 months;caregiver burdenTimepoint: at baseline;non-cancer life expectancyTimepoint: baseline;oncology related parameters: types of malignancy, staging, treatment plannedTimepoint: at baseline;treatment abandonment, lost to follow up, overall survival, and disease-free survival in these patientsTimepoint: 3 months, 6 months and 1 year;correlation of different geriatric conditions, clinical parameters, laboratory parameters with different outcomes (chemotherapy toxicity, overall survival, and quality of life) of the patientsTimepoint: 3, 6 and 12 months;impact of different individualized interventions (geriatric-assessment based, change in medical management) on different outcomes (chemotherapy toxicity, overall survival, and quality of life, patients and caregiver satisfaction)Timepoint: 3,6 and 12 months

Countries

India

Contacts

Public ContactDr NIDHI SONI

AIIMS, New Delhi India

nidhisoni1962@gmail.com08527118534

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026